Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04006262
Title Pre-operative Nivolumab and Ipilimumab, Followed by Post-operative Nivolumab, for MSI/dMMR Oeso-gastric Adenocarcinoma. (NEONIPIGA)
Acronym NEONIPIGA
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors GERCOR - Multidisciplinary Oncology Cooperative Group
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
CHRU Jean Minjoz RECRUITING Besançon France Details
Hôpital Henri Mondor RECRUITING Créteil France Details
Institut Hospitalier Franco-Britannique RECRUITING Levallois-Perret France Details
CHRU Lille NOT_YET_RECRUITING Lille France Details
Centre Léon Bérard RECRUITING Lyon 69373 France Details
Hôpital Privé Jean Mermoz NOT_YET_RECRUITING Lyon France Details
ICM Val d'Aurelle NOT_YET_RECRUITING Montpellier France Details
CHU Nantes NOT_YET_RECRUITING Nantes France Details
Hôpital Européen Geroges Pompidou RECRUITING Paris France Details
Hôpital Saint Antoine RECRUITING Paris France Details
Hôpital Saint Louis RECRUITING Paris France Details
Institut Mutualiste Montsouris NOT_YET_RECRUITING Paris France Details
CHU Poitiers RECRUITING Poitiers France Details
CHU Pontchaillou Rennes RECRUITING Rennes 35033 France Details
CHU Toulouse NOT_YET_RECRUITING Toulouse France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field